Results 201 to 210 of about 645,902 (311)
Is chronic neck pain related to scapular dyskinesia? A systematic review. [PDF]
Javdaneh N +3 more
europepmc +1 more source
Change of the Posture and Pressure Pain Threshold of Neck and Shoulder when using a Smartphone
Hye Jeon
openalex +1 more source
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen +2 more
wiley +1 more source
Effects of kinesiotaping combined with physical therapy in patients with migraine-associated neck pain: a randomized controlled study. [PDF]
Biber EK, Polat B.
europepmc +1 more source
Objective The pharmacodynamic effects of litifilimab on type I interferon (IFN) response and correlations with clinical outcomes were investigated in systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). Methods Participants from part A (SLE) or part B (CLE with or without SLE) of the randomized phase 2 LILAC trial who received ...
Richard Furie +8 more
wiley +1 more source
Chronic neck pain as an exacerbating factor for depressive symptoms in a 1-Year longitudinal population study. [PDF]
Song S, Jeong J, Yum J, Kim KM, Chu MK.
europepmc +1 more source
Background Polymyalgia rheumatica (PMR) is an age‐related inflammatory disease with shoulder‐hip girdle involvement. Magnetic resonance imaging (MRI) reveals extracapsular/entheseal soft tissue involvements in both PMR and spondyloarthritis (SpA) with sacroiliac joint and peri‐entheseal spinal bone marrow oedema (BMO) being characteristic of SpA ...
Kerem Abacar +12 more
wiley +1 more source
Vibro-tactile stimulation of the neck reduces pain in people with cervical dystonia: a proof-of-concept study [PDF]
Jiapeng Xu +12 more
openalex +1 more source
A randomized, placebo‐controlled trial of hydroxychloroquine in incomplete lupus
Objectives Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity and incidence of SLE. Methods Hydroxychloroquine (HCQ) was chosen as an
Nancy J. Olsen +14 more
wiley +1 more source

